Radioligand Binding Studies of Agonist Interactions with Dopamine Receptors
暂无分享,去创建一个
D. Sibley | I. Creese | S. Leff | M. Hamblin
[1] M. Kuhar,et al. Neurotransmitter Receptor Binding , 1984 .
[2] I. Creese,et al. Dopaminergic D-3 binding sites are not presynaptic autoreceptors , 1983, Nature.
[3] D. Sibley,et al. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors. , 1983, Molecular pharmacology.
[4] D. Sibley,et al. Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification. , 1983, The Journal of biological chemistry.
[5] D. Sibley,et al. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. , 1983, Molecular Pharmacology.
[6] I. Creese,et al. Solubilization of D-2 dopamine receptors from canine caudate: agonist-occupation stabilizes guanine nucleotide sensitive receptor complexes. , 1982, Biochemical and biophysical research communications.
[7] D. Sibley,et al. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. , 1982, Life sciences.
[8] D. Sibley,et al. Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. , 1982, The Journal of biological chemistry.
[9] I. Creese,et al. 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. , 1982, Life sciences.
[10] J. Ramsdell,et al. Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix. , 1982, The Journal of clinical endocrinology and metabolism.
[11] M. Korner,et al. Locking of hormone in the beta-adrenergic receptor by attack on a sulfhydryl in an associated component. , 1982, The Journal of biological chemistry.
[12] F. Labrie,et al. The dopamine receptor in the intermediate lobe of the rat pituitary gland is negatively coupled to adenylate cyclase. , 1982, Life sciences.
[13] R. Lefkowitz,et al. Interactions of Agonists with Platelet α2-Adrenergic Receptors , 1982 .
[14] P. Molinoff,et al. Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors. , 1982, The Journal of biological chemistry.
[15] N. Bacopoulos. Acute changes in the state of dopamine receptors; in vitro monitoring with 3H-dopamine. , 1981, Life sciences.
[16] J. P. Schwartz,et al. Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[17] N. E. Larsen,et al. Two different modifications of the neuroblastoma X glioma hybrid opiate receptors induced by N-ethylmaleimide. , 1981, Molecular pharmacology.
[18] M. Titeler,et al. Direct binding of 3H-lisuride to adrenergic and serotonergic receptors. , 1981, Life sciences.
[19] J. Kebabian,et al. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor , 1981, Nature.
[20] A. Camerman,et al. On the stereochemistry of dopaminergic ergoline derivatives. , 1981, Molecular pharmacology.
[21] G. Giannattasio,et al. Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. , 1981, Life sciences.
[22] L. Limbird. Activation and attenuation of adenylate cyclase. The role of GTP-binding proteins as macromolecular messengers in receptor--cyclase coupling. , 1981, The Biochemical journal.
[23] I. Creese,et al. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites. , 1981, European journal of pharmacology.
[24] J. Bilezikian,et al. Guanine nucleotide-induced shift in binding affinity for beta-adrenergic agonists in rat reticulocyte and turkey erythrocyte membranes. , 1981, Biochemical pharmacology.
[25] J. P. Long,et al. Proposed dopaminergic pharmacophore of lergotrile, pergolide, and related ergot alkaloid derivatives. , 1981, Journal of medicinal chemistry.
[26] J. Hyttel. Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro. , 1981, Life sciences.
[27] J. Fain,et al. Alpha 2 adrenergic amines, adenosine and prostaglandins inhibit lipolysis and cyclic AMP accumulation in hamster adipocytes in the absence of extracellular sodium. , 1981, Life sciences.
[28] J. Kebabian,et al. The Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: Pharmacological Characterization , 1980 .
[29] M. Martres,et al. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors , 1980, Nature.
[30] B. Ilien,et al. Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum , 1980, FEBS letters.
[31] M. Maguire,et al. Inactivation of beta-adrenergic receptors by N-ethylmaleimide in S49 lymphoma cells. Agonist induction of functional receptor heterogeneity. , 1980, Molecular pharmacology.
[32] A. Grossman,et al. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells. , 1980, The Journal of endocrinology.
[33] P. Seeman. Brain dopamine receptors. , 1980, Pharmacological reviews.
[34] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[35] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[36] F. Owen,et al. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes. , 1980, European journal of pharmacology.
[37] P. Bédard,et al. The role of D-1 and D-2 receptors , 1980, Nature.
[38] F. Labrie,et al. Modulation of prolactin secretion by sex steroids and thyroid hormones , 1980 .
[39] A. Strosberg,et al. Interaction between beta-adrenergic receptors and guanine nucleotide sites in turkey erythrocyte membranes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Kebabian,et al. Release of α-Melanocyte-Stimulating Hormone from Dispersed Cells of the Intermediate Lobe of the Rat Pituitary Gland: Involvement of Catecholamines and Adenosine 3′,5′-Monophosphate , 1980 .
[41] P. Seeman,et al. High-affinity 3H-dopamine receptors (D3 sites) in human and rat brain. , 1980, Biochemical pharmacology.
[42] J. Clemens,et al. Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists. , 1980, Journal of medicinal chemistry.
[43] S. Snyder,et al. Histamine H1‐Receptor Binding Sites in Guinea Pig Brain Membranes: Regulation of Agonist Interactions by Guanine Nucleotides and Cations , 1980, Journal of neurochemistry.
[44] G. Snyder,et al. Pituitary cyclic nucleotides and thyrotropin-releasing hormone action: the relationship of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate to the release of thyrotropin and prolactin. , 1980, Endocrinology.
[45] A. Strosberg,et al. Inactivation of beta-adrenergic receptors by N-ethylmaleimide: permissive role of beta-adrenergic agents in relation to adenylate cyclase activation. , 1980, Molecular pharmacology.
[46] S. Snyder,et al. Regulation by Cations of [3H]Spiroperidol Binding Associated with Dopamine Receptors of Rat Brain , 1980, Journal of neurochemistry.
[47] P. Devoto,et al. [3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland. , 1980, Life sciences.
[48] H. Glossmann,et al. alpha-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites. , 1980, European journal of pharmacology.
[49] T. Nielsen,et al. The role of the guanine nucleotide exchange reaction in the regulation of the beta-adrenergic receptor and in the actions of catecholamines and cholera toxin on adenylate cyclase in turkey erythrocyte membranes. , 1980, The Journal of biological chemistry.
[50] R. Lefkowitz,et al. Agonist-promoted coupling of the beta-adrenergic receptor with the guanine nucleotide regulatory protein of the adenylate cyclase system. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. Snyder,et al. Species variation in dopamine receptor binding. , 1979, European journal of pharmacology.
[52] Y. Watanabe,et al. Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain. , 1979, Life sciences.
[53] Michael,et al. Dopamine receptor sites in the anterior pituitary. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[54] S. Snyder,et al. Dopamine receptor binding regulated by guanine nucleotides. , 1979, Molecular pharmacology.
[55] I. Creese,et al. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors. , 1979, European journal of pharmacology.
[56] W. Weiner,et al. Amphetamine‐induced hypersensitivity in guinea pigs , 1979, Neurology.
[57] L. Iversen,et al. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain. , 1979, European journal of pharmacology.
[58] P. Seeman,et al. Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine. , 1979, European journal of pharmacology.
[59] A. Strosberg,et al. Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. , 1979, The Journal of biological chemistry.
[60] P. Laduron,et al. Solubilisation of high-affinity dopamine receptors , 1979, Nature.
[61] P. Seeman,et al. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors. , 1979, European journal of pharmacology.
[62] S. Snyder,et al. Guanine nucleotides distinguish between two dopamine receptors , 1979, Nature.
[63] P. Camilli,et al. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas , 1979, Nature.
[64] M. Thorner,et al. THE EFFECTS OF DOPAMINE, BROMOCRIPTINE, LERGOTRILE AND METOCLOPRAMIDE ON PROLACTIN RELEASE FROM CONTINUOUSLY PERFUSED COLUMNS OF ISOLATED RAT PITUITARY CELLS , 1979, Clinical endocrinology.
[65] M. Cronin,et al. [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence. , 1979, Endocrinology.
[66] E. Gardner,et al. Anterior pituitary adenylate cyclase: stimulation by dopamine and other monoamines. , 1979, European journal of pharmacology.
[67] J. Kebabian,et al. Multiple receptors for dopamine , 1979, Nature.
[68] P. Molinoff,et al. Effect of guanine nucleotides on striatal dopamine receptors , 1978, Nature.
[69] S. Snyder,et al. Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides. , 1978, European journal of pharmacology.
[70] J. Hyttel,et al. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. , 1978, Life sciences.
[71] R. George,et al. Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities. , 1978, Life sciences.
[72] H. Fibiger,et al. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain , 1978, Nature.
[73] R. Lefkowitz,et al. Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. , 1978, Molecular pharmacology.
[74] J. Roberts,et al. Dopamine and dihydroergocryptine binding to the anterior pituitary and other brain areas of the rat and sheep. , 1978, Endocrinology.
[75] T. Mowles,et al. The dopamine receptor of the rat mammotroph in cell culture as a model for drug action , 1978 .
[76] D. Miller,et al. Conformation of dopamine at the dopamine receptor. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[77] S. Snyder,et al. 3H-Apomorphine interactions with dopamine receptors in calf brain. , 1978, European journal of pharmacology.
[78] M. Caron,et al. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. , 1978, The Journal of biological chemistry.
[79] D. Howlett,et al. A comparative study of [3H] haloperidol and [3H] spiroperidol binding to receptors on rat cerebral membranes , 1978, FEBS letters.
[80] P. Seeman,et al. Multiple receptors for brain dopamine. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[81] Furchgott Rf. Pharmacological characterization of receptors: its relation to radioligand-binding studies. , 1978 .
[82] J. Leysen,et al. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.
[83] S. Snyder,et al. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.
[84] S. Snyder,et al. 3H-Spiroperidol labels dopamine receptors in pituitary and brain. , 1977, European journal of pharmacology.
[85] P. Mantegazza,et al. Endocrine profile of ergot alkaloids. , 1977, Life sciences.
[86] J. Fields,et al. Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol , 1977, Brain Research.
[87] S. Snyder,et al. A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood , 1977, Nature.
[88] J. Heindel,et al. Adenylyl cyclase from a prolactin producing tumor cell: the effect of phenothiazines. , 1977, Life sciences.
[89] R. Lefkowitz,et al. Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor. , 1977, The Journal of biological chemistry.
[90] S. Snyder,et al. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.
[91] S. Snyder,et al. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat , 1977, Brain Research.
[92] J. Dumont,et al. The two-step model of ligand-receptor interaction , 1977, Molecular and Cellular Endocrinology.
[93] M. Schmidt,et al. Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary. , 1977, Life sciences.
[94] R. Lefkowitz,et al. Catecholamine binding to the beta-adrenergic receptor. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[95] P. Seeman,et al. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[96] S. Snyder,et al. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. , 1976, Molecular pharmacology.
[97] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[98] P. Cuatrecasas,et al. The mobile receptor hypothesis and "cooperativity" of hormone binding. Application to insulin. , 1976, Biochimica et biophysica acta.
[99] K. Gautvik,et al. A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture. , 1976, Endocrinology.
[100] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[101] P. Seeman,et al. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[102] S. Snyder,et al. Dopamine receptor binding in the corpus striatum of mammalian brain. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[103] S. Snyder,et al. Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. , 1975, Life sciences.
[104] T. Hökfelt,et al. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. , 1974, Medical biology.
[105] S. Snyder,et al. Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain , 1973, Science.
[106] D. Sibley,et al. The classification of dopamine receptors: relationship to radioligand binding. , 1983, Annual review of neuroscience.
[107] I. Creese,et al. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes. , 1982, Molecular pharmacology.
[108] D. Sibley,et al. Receptor adaptations to centrally acting drugs. , 1981, Annual review of pharmacology and toxicology.
[109] R. Lefkowitz,et al. Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation. , 1980, Annual review of pharmacology and toxicology.
[110] R. Macleod,et al. Central and peripheral regulation of prolactin function , 1980 .
[111] M. Goldstein. Ergot compounds and brain function : neuroendocrine and neuropsychiatric aspects , 1980 .
[112] P. Molinoff,et al. Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues. , 1980, Journal of cyclic nucleotide research.
[113] Weber Hp. The molecular architecture of ergopeptines: a basis for biological interaction. , 1980 .
[114] R. Lefkowitz,et al. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. , 1980, Molecular pharmacology.
[115] P. Seeman,et al. High affinity dopamine receptors (D3) in rat brain. , 1979, Communications in psychopharmacology.
[116] D. Sibley,et al. Radioligand binding studies: evidence for multiple dopamine receptors. , 1979, Communications in psychopharmacology.
[117] S. Snyder,et al. Biochemical Actions of Neuroleptic Drugs: Focus on the Dopamine Receptor , 1978 .
[118] A. Levitzki. The mode of coupling of adenylate cyclase to hormone receptors and its modulation by GTP. , 1978, Biochemical pharmacology.
[119] W. H. Aellig,et al. Ergot Alkaloids and Related Compounds , 1978, Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie.
[120] R. Macleod,et al. Binding of dopamine to bovine anterior pituitary gland membranes. , 1978, Neuroendocrinology.
[121] J. Hyttel. A comparison of the effect of neuroleptic drugs on the binding of 3H-haloperidol and 3H-cis(Z)-flupenthixol and on adenylate cyclase activity in rat striatal tissue in vitro , 1978 .
[122] J. Clemens,et al. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids. , 1972, Endocrinology.